Breaking

U.S. moves closer to clearing Moderna and J&J Covid booster shots this week - CNBC
Oct 11, 2021 1 min, 20 secs

Millions of Americans will be one step closer to receiving a Covid-19 booster shot this week when a key Food and Drug Administration advisory panel meets Thursday and Friday to debate extra doses of the Moderna and Johnson & Johnson vaccines.

regulators authorized Covid booster shots of Pfizer and BioNTech's vaccine to a wide array of Americans, including the elderly, adults with underlying medical conditions and those who work or live in high-risk settings like health and grocery workers.

moves closer to clearing Moderna and J&J Covid booster shots this week  .

The FDA advisory group is scheduled Thursday to discuss data on the safety and effectiveness of a Moderna booster shot in adults.

On Friday, the committee is expected to debate J&J booster shots for adults.

Last month, Moderna said a third shot at half the dosage used for the first two jabs was safe and produced a stronger immune response than what was seen after the second dose in its phase three clinical trial.

The FDA could authorize Moderna and J&J booster shots under the same criteria as Pfizer or perhaps change course and broaden the number of Americans eligible to receive extra shots, Baylor said in a phone interview.

Committee members will have to debate whether its safe and effective for J&J recipients to get a second dose, Baylor said?

"If I were at the FDA in my old position, I probably would not have taken the Moderna to the advisory committee because it's in the same class as Pfizer," he said

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED